|
Indian Journal of Medical Sciences
Medknow Publications on behalf of Indian Journal of Medical Sciences Trust
ISSN: 0019-5359 EISSN: 1998-3654
Vol. 60, Num. 4, 2006, pp. 162-169
|
Indian Journal of Medical Sciences, Vol. 60, No. 4, April, 2006, pp. 162-169
Practitioners section
Stem cells in orthopedics: Current concepts and possible future applications
Bagaria Vaibhav, Patil Nilesh, Sapre Vikram, Chadda Anshul, Singrakia Manoj
Dept. of Orthopedics, CIIMS HOSPITAL, 88/2, Bajaj Nagar, Nagpur - 440 010
Correspondence Address:Dr.Vaibhav Bagaria, Dept. Of Orthopedics, CIIMS
Hospital, 88/2, Bajaj Nagar, Nagpur - 440 010, India. E-mail: vaibhavbagaria@rediffmail.com
Code Number: ms06026
Abstract Stem cells are the cells that have the ability to divide for indefinite periods in culture and to give rise to specialized cells. Sources of these cells include embryo, umbilical cord and certain sites in adults such as the central nervous system [CNS] and bone marrow. Its use hold promise of wide spread applications particularly in areas of spinal cord injury, difficult non-unions, critical bone defects, spinal fusions, augmentation of ligament reconstructions, cartilage repair and degenerative disc disorders. This review article contains current information derived from Medline searches on the use in various orthopedic subspecialties. Some issues remain at the forefront of the controversy involving stem cell research - legislation, ethics and public opinion, cost and concentration methods. As is true with any new technology, the enthusiasm for this technology that has potential to influence virtually every orthopedic case management, must be balanced by subjecting it to stringent clinical and basic research investigations.
Keywords: Stem cells, spinal cord regeneration, non-union, cartilage repair.
Introduction
A stem cell is a cell that has the ability to divide for indefinite periods - often through out the life of an organism. The stem cells, when provided with the right signals, have the potential to differentiate into different types of cells that constitute an organism. These cells when differentiated can have a characteristic shape and specialized functions, such as heart cells, skin cells or nerve cells.[1],[2] In short, stem cells have two distinctive properties, one they can make identical copies of themselves for a long period of time (self renewal) and two give rise to mature cells that have a characteristic morphology.
Typically stem cell generates an intermediate cell type or different
cell types prior to achieving a mature differentiated state.[3] The
intermediate cell is called a precursor or progenitor cell. Precursor
or progenitor cells in fetus or adults are partly differentiated cells
and eventually divide and give rise to mature differentiated cell. These
cells are often committed meaning that they tend to differentiate only
along a particular cellular development pathway; however, some recent
studies have shown that this may not be as definitive as was once thought.
Their use in orthopedics has gained a significant momentum in past
few years and the field is witnessing some path breaking research currently.
This review article contains current information derived from Medline
searches on their use in various orthopedic subspecialties.
Sources of stem cell
Stem cells are derived from three main sources: embryos, adults
and the umbilical cord.
Embryonic stem cells: These stem cells are defined by their
origin, which is from one of the earliest stages of development of the
embryo called blastocyst. More specifically these are derived from the
inner cell mass of the blastocyst at a stage before it would implant
in the uterine wall. These cells can self replicate and are pleuripotent.[4],[5],[6],[7]
Adult stem cell: It is an undifferentiated cell that is found
in a differentiated tissue, it can renew itself and become specialized
to yield all the specialized cell types of the tissue from which it originated.
Sources of adult stem cell have been found in the bone marrow, blood
stream, cornea and retina of the eyes, the dentine, liver, skin, pancreas
and gastro intestinal tract. In contrast to the embryonic stem cells,
these are not capable of forming all the cells of the body that is they
are not pleuripotent. Adult stem cells are rare and their primary function
is to maintain homeostasis and to a certain extent repair and replace
the cells that die because of injury or disease. Adult stem cells are
dispersed throughout a mature animal and behave very differently depending
on the local milieu. Another feature that distinguishes the adult stem
cell from the embryonic stem cell is the fact that adult stem cells share
no common features and thus have no means of characterization; as opposed
to these the embryonic stem cells can be defined by their origin that
is the inner cell mass of blastocyst. The origin of the adult stem cells
remains a controversy till date. The most accepted hypothesis suggests
that the stem cells are somehow set-aside during the fetal development
and restrained from differentiating.[8],[9],[10],[11],[12],[13],[14],[15],[16]
Umbilical cord stem cells: These are cells harvested from the
cord blood. Cord blood is rich in the stem cells and after appropriate
human leukocyte antigen [HLA] matching may be used to treat a variety
of conditions. Characteristics of these cells are identical to adult
stem cells except that they are not derived from adults and that their
concentration is far more in umbilical blood as compared to adults. The
use of umbilical cord stem cells in orthopedics is still in a nascent
stage and most studies currently focus on the use of the adult stem cell.[17],[18]
Orthopedic applications
Spinal Cord Regeneration
Injury to neural tissue results in a permanent deficit as neurons do
not have the ability to repair or regenerate. Isolation and preparation
of specific population of adult stem cells have evolved to the point
of a stable, long term culturing with capacity to differentiate into
neural phenotypes from all three neural lineages: neurons, astrocytes
and oligodendrocytes. In animal experiments different varieties of adult
stem cells viz -olfactory ensheathing cells, cultured spinal cord stem
cells and dermis-derived stem cell have been implanted in a rat model
of spinal cord injury. And although no definite conclusions were reached
on which of them is best for neural injuries, each of these showed ability
to incorporate into spinal cord, differentiate and improve the locomotor
capability.[27] The presence
of neural stem cells [NSC] in the adult mammalian spinal cord suggests
the latent capacity of regeneration of injured spinal cord if the NSC
are activated properly. In this situation it is crucial to understand
the underlying mechanisms of maintenance, activation and differentiation
of neural stem cells and subsequent process, including the migration,
survival and functional maturation of differentiated cells which may
be possible by further studies.[28],[29] Experiments
involving the use of human umbilical cord blood, a rich source of non-embryonic
stem cells, showed that cord blood derived stem cells migrate and participate
in the healing of neurological defects caused by traumatic assault. Human
experiments involving paraplegic people is still a distant future in
most nations of the world; however, certain reports that have originated
from main land China and Portugal has concurred with results of animals
experiments in terms of improvement in neurological recovery following
stem cell infusions.[30]
Critical Bone Defects and Non-unions
Critical defect is defined as a loss of a portion of bone that
fails to heal and requires a bone reconstruction to prevent a non-union
defect.
The ideal modality for management of these defects have so far been the
autologous bone grafting procedures, but since the amount of the autologous
bone graft that can be harvested remains limited and also conditions
like osteoporosis precludes its use, alternatives are aggressively being
explored. Some investigators have directed their attention towards the
use of autologous non hematopoetic /progenitor cell contained in the
adult bone marrow stroma (also referred to as adult stromal cell). Two
methods have been employed in the pre-clinical and clinical protocols
while managing the critical defects. In one of the protocols the stem
cells were directly injected at the lesion site and in other they were
expanded ex vivo before being implanted. The authors concluded that both
the approaches were equally correct in principle but will require further
studies to demonstrate unambiguously their efficacy in such conditions.[31],[32]
Cartilage Repair
Most authors agree that biologic solutions in treating cartilage
injuries and degeneration would be preferable over the joint arthroplasties.
Recently the researchers are reviewing the use of periosteal derived
stem cells in the repair of osteochondral defects for a variety of reasons.
Primarily the cells can be easily expanded in culture and are phenotypically
stable as well as they are ideal for the delivery of various genes promoting
the repair, maintenance and anabolic metabolism of the cartilage injuries.[33] Adult
stem cells appear to be an attractive option as progenitor cells for
cartilage due to their documented osteogenic and chondrogenic potential.
The differentiation of mesenchymal stem cells [MSC] along chondrogenic
lineage may be a possibility in near future by a multi disciplinary approach
involving the molecular medicine, biomedical engineering, polymer chemistry,
cell biology and clinical orthopedics to get an insight in regulatory
mechanisms controlling the lineage transitions and maturation of cartilaginous
tissue.[34],[35]
ACL Reconstruction Augmentation
In a preclinical study conducted on 48 rabbits for ACL reconstructions
coated with stem cells, it was proved that incorporation of stem cells
resulted in healing by formation of the intervening zone of cartilage
resembling the chondral enthesis of normal ACL insertions rather than
collagen fibers and scar tissue. Biomechanically, ACL reconstructions
enhanced with stem cells had better strength and stiffness. Stem cells
have the potential to provide stronger ligament reconstructions physiologically
and biomechanically in the near future.[36] Meniscal
tears in the avascular zone have limited capacity to heal due to inadequate
blood supply. In a pre-clinical study conducted on Sprague-Dawley rats
by transplanting mesenchymal stem cells into meniscal defects it was
observed that MSC could survive and proliferate in the meniscal defects.
MSC transplantation appears o promising new strategy for treatment of
meniscal tears in avascular zone.[37]
Muscular Dystrophies
Muscular dystrophies are
group of disorders, which are
associated with serious clinical
implications,
but
there is
still no cure. Myoblast
transfer
therapy has long been viewed as a potential therapy for Duchenne′s
muscular dystrophy which entails transplantation of committed mouse precursor
cells into the muscle cells but has had limited success in clinical trials.
The recent discovery of the population of cells within adult muscle with
stem cell like characteristics may have great impact in future advances
in transplantation therapies for muscular dystrophies.[38],[39]
Spine Fusion
In a study conducted on a murine model, spine fusion was achieved by
injecting genetically engineered MSC into the paravertebral muscles. It
was observed that spine fusion can be achieved by engineered mesenchymal
stem cells that conditionally express bone morphogenetic protein-2 and the
extent and quantity of the newly formed bone can be monitored by controlling
the duration of rhBMP-2 gene expression .[40] Use
of marrow derived stem cell along with allograft to achieve spinal fusion
has been supported by many authors when significant quantity of osteogenic
tissue is required. Secondly it has been hypothesized that mesenchymal
stem cells are deficient at fusion site in certain situations [e.g. smokers,
posterolateral fusion beds, cases of failed fusions]. In such scenarios
introduction of stem cells can aid in bone healing and also shorten the
duration of spine fusion.[41],[42]
Intervertebral Disc Degeneration
Intervertebral disc degeneration is manifested by gradual loss of water
and proteoglycans within the intervertebral disc, which may be due to inability
of the ageing disc cells to maintain their structural integrity. Recently
mesenchymal stem cells have been found to have the potential to differentiate
into nucleus pulposis like cells capable of synthesizing proteogylcans
rich extracellular matrix characteristic of healthy intervertebral disc
when exposed to appropriate microenvironment (hypoxia, three dimensional
culture).[44],[45] Although
the problems pertaining to proliferation of stem cells within degenerative
disc need to be overcome, the potential for MSC therapy to retard or reverse
degenerative process appears significant.[46],47
Challenges and the Road Ahead
Some issues remain at the forefront of the controversy involving
stem cell research - legislation, ethics and public opinion, cost and
concentration
methods. Legislations regarding the use of stem cells vary among different
countries as does the public opinion and the moral high grounds assumed
by various political and religious groups.
Researchers argue that many of the embryos created by in vitro fertilization
programs are surplus to requirements and are in any case normally destroyed.
These can be potentially used for the derivation of ES cells.
Costs involved in stem cell research is astronomical and thus is limited
to centers that can invest huge sums of money for various projects.
This cost is eventually passed on to patients and the health care
system. With time however it is expected that cost would bottom down
and the
technology
may be affordable to most candidate patients.
One of the challenges that clinicians face while using the adult
stem cell is that of concentrating the cells. The normal concentration
of
stem cells
in samples drawn from marrow is many a times considered inadequate
for use in most scenarios. Various techniques like filtration,
culture expansion
and sieving are employed for this purpose.
Success of stem cells pertaining to various modalities has been
limited by problems of dosage, lack of activity of the recombinant
factor
and the inability to sustain the presence of a factor for an
appropriate length
of time. Also the risk of forming unwanted tissues and teratocarcinomas
by the stem cells require further evaluation and long term follow
ups.48
Conclusion
The use of stem cell in orthopaedics has provided a new arena for managing complex conditions. Its use holds promise of wide spread applications particularly in areas of spinal cord injury, difficult non- unions, cartilage repair and degenerative disc disorders.
However, its use at present times is restricted by lacunas in our knowledge
in differentiating potentials of these cells and concerns over the long
term stability of repair tissue derived from these cells. In view of
concerns raised by certain politico-religious groups and also as with
any new technology, the enthusiasm for this technology that has potential
to influence virtually every orthopedic case management must be balanced
by subjecting it to stringent clinical and basic research investigations.
References
1. | Harley CB, Gearhart J, Jaenisch R, Rossant J, Thomson J. Pluripotent stem cells: Biology and applications. Durango Publisher Co: 2001. Back to cited text no. 1 |
2. | Leblond CP. Classification of cell populations on the basis of their proliferative behavior. Nat Cancer Inst Pub 1964;14;119-50. Back to cited text no. 2 |
3. | Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med 2001;7:393-5. Back to cited text no. 3 [PUBMED] [FULLTEXT] |
4. | Buttery LD, Bourne S, Xynos JD, Wood H, Hughes FJ, Hughes SP, et al . Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 2001;7:89-99. Back to cited text no. 4 |
5. | Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-6. Back to cited text no. 5 [PUBMED] |
6. | Jones JM, Thomson JA. Human embryonic stem cell technology. Semin Reprod Med. 2000;18:219-23. Back to cited text no. 6 [PUBMED] |
7. | Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001;19:193-204. Back to cited text no. 7 [PUBMED] [FULLTEXT] |
8. | Bianco P, Riminucci M, Kuznetsov S, Robey PG. Multipotential cells in the bone marrow stroma: Regulation in the context of organ physiology. Crit Rev Eukaryot Gene Expr 1999;9:159-73. Back to cited text no. 8 [PUBMED] |
9. | Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: Nature, biology and potential applications. Stem Cells 2001;19:180-92. Back to cited text no. 9 [PUBMED] [FULLTEXT] |
10. | Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64:278-94. Back to cited text no. 10 [PUBMED] [FULLTEXT] |
11. | Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966;16:381-90. Back to cited text no. 11 [PUBMED] |
12. | Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999;96:10711-6. Back to cited text no. 12 [PUBMED] [FULLTEXT] |
13. | Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. H Circulating skeletal stem cells. J Cell Biol 2001;153:1133-40. Back to cited text no. 13 [PUBMED] [FULLTEXT] |
14. | Raisman G. Olfactory ensheathing cells - another miracle cure for spinal cord injury? Nat Rev Neurosci 2001;2:369-75. Back to cited text no. 14 [PUBMED] [FULLTEXT] |
15. | Pittenger MF, Marshak DR. Mesenchymal stem cells of human adult bone marrow. Marshak DR, Gardner DK and Gottlieb D. editors. Cold Spring Harbor Laboratory Press. Cold Spring Harbor: New York; 2001. p. 349-74. Back to cited text no. 15 |
16. | Moise KJ Jr. Umbilical cord stem cells. Obstet Gynecol 2005;106:1393-407. Back to cited text no. 16 [PUBMED] [FULLTEXT] |
17. | Tse W, Laughlin MJ. Umbilical cord blood transplantation: A new alternative option. Hematology (Am Soc Hematol Educ Program) 2005;377-83. Back to cited text no. 17 |
18. | Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4:267-74. Back to cited text no. 18 [PUBMED] |
19. | Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, et al . Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice. Proc Natl Acad Sci USA 1995;92:4857-61. Back to cited text no. 19 |
20. | Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, et al . Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000;164:247-56. Back to cited text no. 20 |
21. | Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA 1997;94:4080-5. Back to cited text no. 21 [PUBMED] [FULLTEXT] |
22. | Sakai T, Li RK, Weisel RD, Mickle DA, Kim EJ, Tomita S, et al . Autologous heart cell transplantation improves cardiac function after myocardial injury. Ann Thorac Surg 1999;68:2074-80; discussion 81. Back to cited text no. 22 |
23. | Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al . Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705. Back to cited text no. 23 |
24. | Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, et al . Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx. Anat Embryol (Berl) 1999;199:391-6. Back to cited text no. 24 |
25. | Cazillis M, Rasika S, Mani S, Gressens P, Lelievre V. In vitro induction of neural differentiation of embryonic stem (ES) cells closely mimics molecular mechanisms of embryonic brain development. Pediatr Res 2006;59:48R-53R. Back to cited text no. 25 [PUBMED] [FULLTEXT] |
26. | Okano H, Okada S, Nakamura M, Toyama Y. Neural stem cells and regeneration of injured spinal cord. Kidney Int 2005;68:1927-31. Back to cited text no. 26 [PUBMED] [FULLTEXT] |
27. | Bambakidis NC, Theodore N, Nakaji P, Harvey A, Sonntag VK, Preul MC, et al. Endogenous stem cell proliferation after central nervous system injury: alternative therapeutic options. Neurosurg Focus 2005;19:E1. Back to cited text no. 27 [PUBMED] |
28. | McDonald JW, Becker D, Holekamp TF, Howard M, Liu S, Lu A, et al . Repair of the injured spinal cord and the potential of embryonic stem cell transplantation. J Neurotrauma 2004;21:383-93. Back to cited text no. 28 |
29. | Lucarelli E, Donati D, Cenacchi A, Fornasari PM. Bone reconstruction of large defects using bone marrow derived autologous stem cells. Transfus Apher Sci 2004;30:169-74. Back to cited text no. 29 [PUBMED] [FULLTEXT] |
30. | Caplan AI. Review: mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics. Tissue Eng 2005;11:1198-211. Back to cited text no. 30 [PUBMED] [FULLTEXT] |
31. | Magne D, Vinatier C, Julien M, Weiss P, Guicheux J. Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med. 2005;11:519-26. Back to cited text no. 31 [PUBMED] [FULLTEXT] |
32. | Solchaga LA, Welter JF, Lennon DP, Caplan AI. Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. Methods Mol Med 2004;100:53-68. Back to cited text no. 32 [PUBMED] [FULLTEXT] |
33. | Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003;48:3464-74. Back to cited text no. 33 [PUBMED] [FULLTEXT] |
34. | Lim JK, Hui J, Li L, Thambyah A, Goh J, Lee EH. Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction. Arthroscopy 2004;20:899-910. Back to cited text no. 34 [PUBMED] [FULLTEXT] |
35. | Izuta Y, Ochi M, Adachi N, Deie M, Yamasaki T, Shinomiya R. Meniscal repair using bone marrow-derived mesenchymal stem cells: Experimental study using green fluorescent protein transgenic rats. Knee. 2005;12:217-23. Back to cited text no. 35 [PUBMED] [FULLTEXT] |
36. | Lee-Pullen TF, Grounds MD. Muscle-derived stem cells: Implications for effective myoblast transfer therapy. IUBMB Life 2005;57:731-6. Back to cited text no. 36 [PUBMED] [FULLTEXT] |
37. | Zhang C, Feng HY, Huang SL, Fang JP, Xiao LL, Yao XL, et al . Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005;22:399-405. Back to cited text no. 37 |
38. | Hasharoni A, Zilberman Y, Turgeman G, Helm GA, Liebergall M, Gazit D. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J Neurosurg Spine 2005;3:47-52. Back to cited text no. 38 [PUBMED] |
39. | Risbud MV, Shapiro IM, Guttapalli A, Di Martino A, Danielson KG, Beiner JM, et al . Osteogenic potential of adult human stem cells of the lumbar vertebral body and the iliac crest. Spine 2006;31:83-9. Back to cited text no. 39 |
40. | Cinotti G, Patti AM, Vulcano A, Della RC, Polveroni G, Giannicola G, et al . Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells. J Bone Joint Surg Br 2004;86:135-42. Back to cited text no. 40 |
41. | Muschler GF, Nitto H, Matsukura Y, Boehm C, Valdevit A, Kambic H, et al . Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 2003;407:102-18. Back to cited text no. 41 |
42. | Risbud MV, Shapiro IM, Vaccaro AR, Albert TJ. Stem cell regeneration of the nucleus pulposus. Spine J 2004;4:348S-53S. Back to cited text no. 42 [PUBMED] [FULLTEXT] |
43. | Acosta FL Jr, Lotz J, Ames CP. The potential role of mesenchymal stem cell therapy for intervertebral disc degeneration: A critical overview. Neurosurg Focus 2005;19:E4. Back to cited text no. 43 [PUBMED] |
44. | Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, et al. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine 2005;30:2379-87. Back to cited text no. 44 [PUBMED] [FULLTEXT] |
45. | Sakai D, Mochida J, Iwashina T, Hiyama A, Omi H, Imai M, et al . Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials 2006;27:335-45. Back to cited text no. 45 |
46. | Vats A, Tolley NS, Buttery LD, Polak JM. The stem cell in orthopaedic surgery. J Bone Joint Surg Br.2004;86:159-64. Back to cited text no. 46 [PUBMED] [FULLTEXT] |
Copyright 2006 - Indian Journal of Medical Sciences
|